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ABSTRACT  
This review conceptualizes about the actinomycetes and its contribution to human health by playing a key role as bioactive secondary metabolites, 
such as enzymes, antibiotics and pigments, leading to their diverse applications and use in various industries. These searches have been 
uncommonly successful, and around 66% of naturally happening antibiotics, including many medically important, have been isolated from 
actinomycetes. The speedy occurrence of antimicrobial resistance among pathogens has led to a renewed interest to search for novel antimicrobial 
agents, but these antibiotics are not enough for the treatment of all diseases because there is a berserk requirement for a novel actinomycetes to 
combat against the antibiotic-resistant strains of pathogenic microorganisms, which are quickly expanding bit by bit. Actinomycetes are the 
important providers to the pharmaceutical and other industries and are well known for their capacity to produce secondary metabolites many of 
which are active against pathogenic microorganisms. 
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The presence of actinomycetes has been known for over hundred 
years. For much of the time they were seen as a foreign group of 
organisms with an attraction to both bacteria and fungi. However, the 
study of their fine structure and chemical composition started in the 
1950s, having confirmed their prokaryotic nature. They now create 
the order actinomycetales and their removal from the mycologists, has 
ruined the effective reach. Their difference in status paralleled that of 
the blue-green growth to the cyanobacteria but it was accepted more 
rapidly and less bitterly. It is not easy to give a short, accurate 
definition of actinomycetes. They are frequently described as bacteria 
which have the ability to form branching hyphae at some stage of their 
development. However, this attribute is unconvincing and it often 
requires the imagination to believe in it [1]. 
The name “actinomycetes” was derived from Greek “atkis” (a ray) 
and “mykes” (fungus) and has features of both bacteria and fungi [2]. 
Actinomycetes are soil organisms which have features common to 
bacteria and fungi and however possess sufficient distinctive 
features to delimit them into a distinct group. They were initially 
erroneously classified as fungi since they have true aerial hyphae 
and form spores, both of which are thought to be fungal 
characteristics [3]. Actinomycetes are characterized as microscopic 
organisms that can shape spreading hyphae at some phase of their 
advancement [4]. They are characterized by having a high guanine 
and cytosine content in their deoxyribonucleic acid [5]. The 
actinomycetes are a group of microbes which possess many 
significant and interesting features. They have given many 
important bioactive compounds of high commercial value and 
continue to be routinely screened for new bioactive substances.  
These searches have been uncommonly successful, and around 66% of 
naturally happening antibiotics, including many of medical significance, 
have been isolated from actinomycetes [6]. One result of intense 
screening programs carried out over the past several years is that there 
is a developing issue of "rediscovery'' of definitely known bioactive 
compounds [7]. This pattern appears to suggest that the effortlessly 
open microorganisms in soil had been depleted and there is a need to 
look for unutilized microorganisms from unexplored sources [8]. 
One way to approach with this issue is to extend the source of 
actinomycetes via ecological evaluations of environments other than 
earthly soils. There is also a growing interest in the non-
streptomycete actinomycetes as sources of novel compounds [7]. It 
is likely that the assorted variety of secondary metabolites depends 
pretty much on the isolation source, viz. the environment of the 
producers [8]. Based on the above beliefs, new actinomycetes strains 
that create active compounds have been as of late removed from 
novel sources including saline, sea, mangrove woodlands and 
specialty natural surroundings, for example, caves, beehives, 
pristine forests, lakes, rivers and other wetlands [9-12], to cope with 
the demand for new pharmaceutical compounds and to resist the 
antibiotic-resistant pathogens. 
Goals of novel actinomycetes research towards contribution to 
the human health  
The war continues between antibiotics and resistant bacteria. More 
the scientists produce new and effective antibiotics, more frequent 
will be the bacteria changing their genetic mutations and adjusting 
their defenses, according to the components of the new antibody 
and win it, every time. To solve the problem of antimicrobial 
resistance there is a need for the discovery of new drugs, which is a 
critical element in a coordinated response to antimicrobial 
resistance. The resistance of bacteria to antibiotics is one of the 
global health and economic problems, prompting researchers to 
look for new antibodies to overcome resistant bacterial strains that 
increase mortality and epidemics. Health experts estimate that 
nearly 90,000 people die each year from antibiotic-resistant bacteria 
in the United States, and hospital-acquired disease develops in more 
than 2 million people annually, and that three-quarters of these 
occur as a result of at least one adverse common antibiotic. 
Antibiotic-resistant bacteria make the patient stay in the hospital for 
a long time, increase the risk of disease and also increase direct 
economic costs of antibiotic-resistant bacteria. For example, the 
infection of Pseudomonas aeruginosa in hospitalized patients, costs $ 
74,040, more than the treatment costs for a sensitive strain, ie., 
patients with Staphylococcus aureus methicillin resistance and may 
cost up to $ 4,000 more than the cost of treating patients with an 
antibiotic-resistant S. aureus strain. The cost of treatment with 
multidrug-resistant TB bacteria is $ 180,000 or more and the cost of 
treatment for sensitive strains is $ 2,000. In general, the total cost 
associated with antibiotic-resistant bacteria is estimated at $ 4-5 
billion per year in the United States [1]. 
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There is a post for new anti-infection agents to treat ailments via 
looking for different sources, for example, actinomycetes to confine 
crude anti-infection agents. Since, now 66% of the anti-infection 
agents utilized as a part of medication are recently separated from 
actinomycetes and numerous more are of therapeutic significance, 
having been secluded from it [6].  
Screening of actinomycetes for the generation of new anti-infection 
agents has been seriously taken after a long time by researchers. 
Anti-microbials have been utilized as a part of numerous fields 
including agribusiness, veterinary and pharmaceutical industry. 
Actinomycetes can integrate various naturally dynamic optional 
metabolites, for example, anti-infection agents, herbicides, 
pesticides, hostile to parasites, and catalysts like cellulase and 
xylanase which are utilized as a part of waste treatment [14]. 
The proceeding with accomplishment of a biotechnologist in the 
hunt of microbial metabolites as antimicrobial mixes (anti-infection 
agents) is helpful in battling human, creature and plant illnesses for 
fortifying the conviction that microorganisms constitute a limitless 
supply of mixes with pharmacological, physiological, medicinal or 
rural applications [15].  
Antibiotic drug discovery is an indispensable process to combat 
aggressive ability of pathogenic microorganisms and emerging 
infectious diseases against health and well-being of people 
throughout the world [16]. According to the updated and expanded 
data on natural products presented by Newman and Cragg [17], the 
utility of natural products as sources of novel structures is still alive 
and the anti-infective area depends on natural products and their 
structures. The natural products with pharmaceutical importance 
are largely produced from primary and secondary metabolism of 
plants and microorganisms. Microbial natural products have made 
an incredible contribution to the antibiotic drug discovery and 
development process over last seven decades [18]. Alexander 
Fleming’s discovery of penicillin from a mold in 1928 and its 
subsequent progress into a medicine in the 1940s laid the 
foundation for development of microbial natural products as drugs 
[19, 20]. Afterwards, according to Waksman's resulting reports of 
actinomycin, streptothricin and streptomycin in 1940, 1942 and 
1943 respectively, actinomycetes was introduced as a source of 
antibiotics [21-23]. At the end of the 20PthP century, diversified 
actinobacterial natural products had found wide utilization in 
clinical field as antibacterial, antifungal, antiparasitic, and anticancer 
agents [24]. According to Berdy [25], out of all studies of bioactive 
compounds of microbial origin, 45% are produced by actinomycetes. 
Moreover, 90% approximately of antibiotics utilized as drugs 
isolated from the actinomycetes and they are as yet being principal 
natural antibiotic producers [26]. Since the report of streptomycin 
from the strains of Streptomyces griseus, there has been a fast 
acceleration in antibiotic discovery from the genus Streptomyces 
(biggest genus of Actinobacteria). Subsequently, members of this 
genus have become renowned as a prime source of natural 
antibiotics [27, 28].  
It has been evidenced by continuing production of string of 
commercially important antibiotics like daptomycin, erythromycin, 
fosfomycin, lincomycin, neomycin, streptomycin, and tetracycline from 
industrially-important members of the genus Streptomyces [29]. 
However, the possibility of novel antimicrobial leads from these 
special actinomycetes has as of late dwindled upon the rediscovery 
of known compounds [30] and the focus of current microbial drug 
discovery programs being reoriented toward other promising 
microbial resources. Other side of the coin, emergence of new 
infectious diseases and antibiotic resistance provoked in earlier 
infectious diseases has raised the need for novel antibiotics. Against 
this background, uncommon actinomycetes (non-streptomycetes) 
are by and by isolated from different habitats and genuinely 
examined for antibiotic discovery programs. The rare actinomycetes 
are generally viewed as strains of actinomycetes whose isolation 
frequency by traditional methods is significantly lesser than that of 
streptomycete strains [31]. According to Tiwari and Gupta [32], this 
non-streptomycete actinomycetes group include diverse bioactive 
secondary metabolite producing members under following genera: 
Actinomadura, Actinoplanes, Amycolatopsis, Dactylosporangium, 
Kibdelosporangium, Kitasatospora, Microbiospora, Planomonospora, 
Planobispora, Salinispora, Streptosporangium, and Verrucosispora. 
The studies have furthermore been expanded by recent studies of 
bioactive compounds from individuals from other rare generators, 
Nonomuraea [33-35], Actinoalloteichus [36, 37], Pseudonocardia [38-
40] and Saccharothrix [41-43]. Furthermore, basic information 
about the habitats, physiology and secondary metabolite diversity of 
the rare actinomycetes have continuously increased [31]. Out of in 
excess of eight thousand antimicrobial products portrayed in the 
ABL database, 16% created by strains have a place with uncommon 
genera of actinomycetes [44]. Allocation of the novel actinomycetes 
has been observed to be wide in terrestrial and aquatic 
environments [31]. Isolation techniques have turned out to be vital 
as these uncommon actinomycetes utilize slow growth while quickly 
growing streptomycetes and fungal strains dominate in ordinary 
actinomycetes isolation methods. Different isolation methods have 
to be used for getting diverse actinomycetes from different sources. 
These methods use a variety of pretreatment techniques and 
enrichment techniques along with specific isolation medium 
improved with specific antimicrobial agents  [45]. In 2013, Tiwari 
and Gupta [46], have reviewed almost all the selective isolation 
methods that have been developed to date for isolation of rare 
actinomycetes. In fact, all the isolation methods are designed to 
favor the growth of rare actinomycetes while suppressing the 
growth of undesired microorganisms. In recent times, much care has 
been given to isolating rare actinomycetes from diverse previously 
unexplored common as well as uncommon extreme environments. 
Numerous rare actinomycetes have been isolated from variety of 
soil samples [31; 47-50], plant materials [51-53], marine sources 
[54-57], extreme saline zones [58], volcanic zones [59], hyper arids 
[60], glaciers [61,62], and much more. Therefore, a variety of 
uncommon actinomycetes accessible for current antimicrobial 
medication screening programs has increased. In the review article of 
Tiwari and Gupta [46] there are reports of isolation of uncommon 
actinomycetes from various natural habitats throughout the world. It 
is disclosed that a surprising assortment of uncommon actinomycetes 
colonize in diverse, previously unexplored natural habitats. Finally, 
rare actinomycetes are being detected as highly prospective sources of 
bioactive compounds. Ways have already been sketched to reach these 
rare microorganisms but steps should be taken with speci fic isolation 
strategies [16]. The developed disclosures of novel bioactive 
compounds from these uncommon actinomycetes (non-
streptomycetes) clearly opine that these organisms contribute to the 
antibiotic drug discovery programs [16]. 
Importance of actinomycetes 
Enzymes 
Different genera of Actinomycetes have been reported to create a 
wide cluster of potential industrial enzymes that can be utilized as a 
part of biotechnological applications and specific biomedical fields 
[63]. Proceeding advances in sequencing technology and 
bioinformatics apparatuses make it conceivable to think about the 
microbial enzyme production by utilizing proteomics and 
metaproteomics [64]. Microbial enzymes assume a key part as 
metabolic catalysts, promoting their different applications and use 
in different industries. The steady look for novel microbial enzymes 
has prompted an act of ad-lib in the industrial procedures which is 
the key pay off growth. Actinomycetes form a noteworthy group of 
microbial populaces in the soil, plant tissues, and marine 
environments. Actinomycetes produce numerous significant 
extracellular enzymes which can break down an assortment of 
organic materials. Enzymes produced by actinomycetes and used in 
various industries are cellulases, proteases, amylases, lipases, 
xylanases, chitinases, cutinases and pectinases (table 1). 
Actinomycetes distinguished from the extreme environments are 
known to be makers of novel enzymes with incredible industrial 
potential [65]. Actinomycetes have been consistently considered and 
utilized for the production of amylases, cellulases, proteases, 
chitinases, xylanases and pectinases. This audit production of 
industrially important enzymes by actinomycetes, their qualities and 
industrial uses (applications in biomedicine, food, cleanser, mash 
and paper, agribusiness, material, and waste administration) are 
commendable.
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Table 1: Significant enzymes produced by actinomycetes 
Enzyme Producing strain Industrial application Reference  
Cellulase Streptomyces ruber Thermobifida halotolerans Detergent, Paper and pulp [66-67]  
Protease Streptomyces pactum and Streptomyces thermoviolaceus Pharmaceutical, Leather, food and detergents [68-69] 
Keratinase Actinomadura keratinilytica and Streptomyces erumpens Leather and detergents [70] 
Amylase Thermobifida fusca and Streptomyces avermitilis Paper, pulp, textile, food, brewing and distilling 
industries 
[71-72]. 
Xylanase Streptomyces spp. And Actinomadura sp. Paper, pulp and Animal feed  [73-74]. 
Lipase Nocardiopsis alba Streptomyces exfoliates Detergent industries, foodstuff, oleochemical, 




Streptomyces thermoviolaceus, Nocardiopsis prasina, 
Streptomyces hygroscopicus and Streptomyces aureofaciens 
Textile and Leather [77-78] 
Pectinase Streptomyces lydicus Beverage and Textile [79-81] 
L-
asparaginase 
Streptomyces griseus, S. karnatakensis, S. albidoflavus and 
Nocardia sp 
therapeutic agent in the cure of certain human 




The discovery of actinomycin was soon replaced by that of 
streptomycin which is most likely best known for its utilization in 
the control of tuberculosis. Numerous other medically helpful 
antibiotics are still being used. Although the greater part of these 
antibiotics began from streptomycetes, other genera, for example, 
Actinoplanes, Actinomadura, and Micromonospora, likewise deliver 
helpful or possibly valuable antibiotics. In spite of the fact that the 
rate of return has diminished as of late, new antibiotics and other 
valuable metabolites from actinomycetes are yet to be found. This 
will be represented by β-lactamase inhibitors, for example, clavulanic 
acid from Streptomyces clavuligerus [83], which has been economically 
produced to surmount bacterial resistance to existing β-lactam 
antibiotics. The capacity of actinomycetes to create valuable secondary 
metabolites stays amazing; in spite of the fact that the purposes behind 
this and biological importance of such products are as yet not clear [84]. 
Moreover, it is a continuous effort to look into new ecological housing for 
novel actinomycetes. Target coordinated screening is being utilized for 
screening of antibiotic-producing actinomycetes. Molecular biology 
methods have helped on a huge scale in finding new antibiotics from 
actinomycetes. The significance of actinomycetes in modern 
biosynthesis has catalyzed many parts of essential research on these 
microbes. The streptomycetes, are the most productive well spring of 
new antibiotics [25, 85, 86]. Actinomycetes are at present known to 
deliver more than 10,000 bioactive compounds, 7,600 of which have 
been isolated from streptomycetes and 2,500 from non-streptomycetes, 
prominently from the so-called rare actinomycetes [87]. 
In spite of this astounding productivity, it has been assessed that only 
tiny part of the aggregate number of antimicrobial compounds which 
actinomycetes can produce have been found to date [88]. Sacrificial 
numbers of bioactive microbial metabolites have appeared in table 1.1. 
Antibiotics created by actinomycetes demonstrate an extensive variety 
of chemical assorted, as exhibited in table 1.2. It is obvious from this 
information that streptomycetes combine a different scope of 
antibiotics; it is likewise realized that particular basic sorts of 
antibiotics happen normally in these organisms, for example, ansa-
lactam rings, macrocyclic lactones, polyether and cyclopeptide 
skeletons [25, 89]. However, certain particular structures are 
produced all the more every now and again by non-streptomycetes, 
for example, actinoplanes and amycolatopsis strains, which are rich 
sources of vancomycin-like glycopeptides [90]. For rare 
actinomycetes, there is a confirmation that taxonomic diversity can be 
utilized as a substitute for substance diversity among actinomycetes, 
particularly at the species level [91-93]. This implies that novel 
actinomycete ought to be a rich source of new bioactive compounds 
[94, 95]. Thus, it promises well to devise specific isolation and 
characterization methodologies to secure delegates of rare 
actinomycete genera for pharmaceutical screening programs, a 
strategy which has been applied with some success [86, 87]. Rare 
actinomycete genera known to synthesize novel antibiotics, as 
exemplified by the genera Actinokineospora, Acrocarpospora, 
Actinosynnema, Amycolatopsis, Catenuloplanes, Cryptosporangium, 
Dactylosporangium, Kineosporia, Kutzneria, Microbispora, Microtetrasp
ora, Nonomuraea, Thermomonospora, Pseudonocardia, Thermobifida, 
Saccharomonospora, Spirilliplanes, Streptosporangium and Virgosporan
gium [45].  
The significance of rare actinomycetes can be exhibited by the way 
that some of them are the source of commercially important anti-
microbial products, as exemplified by erythromycin delivered by 
Saccharopolyspora erythraea [96], gentamicin by Micromonopsora 
purpurea [97, 98], rifamycin by Amycolatopsis mediterranei [99], 
teicoplanin by Actinoplanes teichomyceticus [100, 101] and 
vancomycin by Amycolatopsis orientalis [90]. 
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Table 3: Antibiotics isolated from actinomycete genera, as described in the antibiotic database of the Journal of Antibiotics [6] 
QN POL NUC TC ANC GP PEP BLA AML ML AG Actinomycete 
 Streptomyces 
Other actinomycetes:  
           Actinomadura 
           Actinoplanes 
           Actinosynnema 
           Ampullariella 
           Amycolatopsis 
           Dactylosporangium 
           Kibdelosporangium 
           Kitasatospora 
           Microbispora 
           Micromonospora 
           Microtetraspora 
           Nocardia 
           Nocardiopsis 
           Nonomuraea 
           Pseudonocardia 
           Rhodococcus 
           Saccharomonospora 
           Saccharopolyspora 
           Saccharothrix 
           Streptoalloteichus 
           Streptosporangium 
           Thermomonospora 
AG: aminoglycoside; ML: macrolide; AML: ansamacrolide; BLA: β-lactam; PEP: peptide; GP: glycopeptides; ANC: anthracycline; TC: tetracycline; NUC: 
nucleotide; POL: polyene; QN: quinine: Production 
 
Natural pigments  
Several microscopic organisms will just produce their pigments 
under certain environmental conditions. Different species produce 
pigment as the colonies age or when a particular nutrient is 
available in the media. Pigments can help recognize microscopic 
organisms. For instance, a few microscopic organisms create water-
soluble pigments which spread through the medium in which they 
develop. Others produce pigments that are soluble in fat. To decide 
this, one can expel some of a pigmented colony and shake it in oil. In 
the event that the oil becomes pigmented, the pigment is fat soluble. 
Natural pigments are a superior substitute to chemical dyes utilized 
in the industries and research centers. Out of the numerous types of 
Streptomyces available universally in the soil, S. coelicolor and S. 
violaceoruber produce an important red-blue anti-toxin 
actinorhodin and associated compounds like α-, β-, ε-, actinorhodin 
collectively known as Actinorhodin-related "Blue Pigments". These 
pigments have an extensive variety of utilization in the scientific, 
medical and industrial sector [102]. Microorganisms can create 
distinctive colors, for example, those carotenoids, melanins, flavins, 
quinones, prodigiusens, monacens, violasin or indigo. The 
temperature of the nursery is the primary factor that relies upon the 
kind of microorganisms. Carotenoids are yellow-to-orange red 
pigments found in varieties of plants, bacteria, and fungi [103]. 
Recently, carotenoids are utilized commercially for nutraceuticals, 
beauty care products and pharmaceutical purposes [104]. 
Carotenoids can repress different sorts of cancer and can enhance 
immunity response [105]. It can likewise prevent life-related 
diseases due to its propitamin action and higher antioxidants 
capacity [106]. In future, through the genetic engineering of the 
microbial pathway, enzyme can produce a high measure of 
carotenoids. Since people started to experience the ill effects of 
different infections they started to look for anti-infection agents 
from microorganisms. Numerous bacterial infections caused by 
microorganisms have been resistant to antibiotics which has caused 
a major healthcare problem. So, there is a critical need to research 
into antibiotics against multidrug resistance inflammation. 
Several different combination media have been suggested for 
isolation of actinomycetes, such as for example, starch casein agar 
[107], yeast malt extract agar [108], glycerol asparagine agar [109], 
tyrosine agar [110], glycerol yeast extract agar and starch yeast 
extract agar [111]. Determination of color or pigment production by 
the various isolates: for color determination, the media which had 
been prepared for morphological characterization was used. RAL 
Color Chart was used and color determination was done for mature 
sporulating aerial surface growth, the color of the substrate 
mycelium as seen from the reverse side of the plate and for 
diffusible pigments other than melanin. The color of the aerial 
surface growth was determined as white, gray, yellow, red, blue, 
green and violet. The presence of other soluble colors other than 
melanin pigmentation was determined if soluble colors other than 
brown or black was produced on any medium or if brown was 
distinctively modified with red, yellow, green, blue or violet. 
Actinomycetes are a productive source of secondary metabolites and 
by far most of these compounds are gotten from the single family 
Streptomyces. The actinomycetes have demonstrated their 
significance biotechnologically and industrially. The isolation and 
characterization of actinomycetes are an important approach to 
industrially important natural colors [112]. The isolation of 
actinomycetes from soil were also described by Selvameenal et al., 
[113] and the actinomycetes have a potential for pigment-producing 
ability along with antimicrobial activities. Many industries are using 
the natural pigment producing actinomycete. The study concluded 
that actinomycetes have the ability of diffusible pigment-production 
on different agar media, can open doors for food colors and 
beverage, in the pharmaceutical industry, and can be included in 
cosmetic industries. 
Biological control 
It is well understood that actinomycetes carry out various activities 
in soil: debasement of organic matter; hindrance or stimulation of 
different microorganisms and plant; conversion of the chemical 
compound, for example, herbicides and other horticulturally 
valuable compound and numerous different activities that can only 
be estimated [114]. Soil actinomycetes have fluctuating degrees of 
the inhibitory movement against particular fungi and by and large 
decrease soil fungal populace [115]. 
Streptomyces spp. has been appeared to have characteristics, which 
make them beneficial as biocontrol operators' soil-borne fungal 
plant pathogens. These qualities incorporate the production of 
various sort of secondary metabolites and biologically active 
substances of high commercial value such as enzymes which 
degrade the fungal cell divider straightforwardly and antibiotics. 
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They are one of the major contributors to the biological buffering of 
the soil and have roles in the decomposition of organic matter 
conducive to crop production [1, 116]. 
Plant growth enhancement 
The free-living actinomycetes has been in the improvement of plant 
development, where that more actinomycetes isolated from the 
rhizosphere of pine produced B vitamins, since mycorrhizae require 
these vitamins and are known to upgrade the growth of the plants. It 
was recommended that actinomycetes may in this indirectly 
contribute to plant development stimulation [117]. 
In another investigation, actinomycetes, added to the soil to control 
black rot of peanuts caused by Cylindrocladium crotalariae, did not 
increase control of the disease, but did, in some status measurably 
increase plant development [118]. 
Biotechnology 
The consideration given to the actinomycetes in biotechnological 
applications is a characteristic consequence of the immense 
metabolic assorted variety of these living beings and their long 
relationship with the earth and needs of people. Other valuable 
activities of actinomycetes identified with biotechnology is their 
gene expression activity which is becoming an active research 
region [119]. 
Waste management 
Wastes from food processing transactions contain the huge measure 
of starch [120]. Amylolytic actinomycetes may be utilized for 
bioconversion of such wastes. A few mesophilic streptomyces 
strains have been appeared to create amylase that hydrolyse starch 
and crude starch granules to maltose [121]. The amylases of 
thermophilic actinomycete have more mercantile potential than 
those of mesophilic Streptomyces e. g. Thermoactinomyces vulgaris is 
a good producer of a heat stable, highly active amylase. 
Cyanide and other dangerous metals are produced on the industrial 
scale for use in the metal extraction, electroplating, and steel industry. 
In nature cyanide can be acclimatized or detoxified by plants. Certain 
microorganisms likewise can decompose cyanide to formamide, 
ammonia and carbon dioxide or cyaloalanine. Streptomyces lavendulae 
is observed to be a degrader of cyanide. It has a rhodanase enzyme 
that transfers sulfur from sodium thiosulphate to cyanide, forming 
thiocyanate [122]. Actinomycetes incorporate an extensive variety of 
mesophilic and thermophilic strains which break down lignocellulosic 
plant sediment [123]. Members of many species included have the 
potential for use in the bioconversion of under-used rural and urban 
wastes into high worth chemical products [124]. 
CONCLUSION 
Actinomycetes are of great importance since they have the ability to 
contribute to human well-being through the production of 
antimicrobial agents and other industrial products like enzymes, 
drugs and natural pigments. Actinomycetes are at present known to 
deliver more than 10,000 bioactive compounds, 7,600 of which have 
been isolated from streptomycetes and 2,500 from non-
streptomycetes, prominently from the so-called rare actinomycetes. 
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